Finasteride: Effects, Side Effects, Dosage, and Experiences Against Hair Loss

What is finasteride and how does it work?

Finasteride is a prescription-only medication that slows hereditary hair loss in men by lowering DHT, the hormone that damages the follicle. Pharmacologically, finasteride is a 4-azasteroid and a selective inhibitor of type II 5-alpha-reductase. Its effect rests on blocking this enzyme, which converts testosterone into the far more potent dihydrotestosterone (DHT). According to the Propecia prescribing information (Organon, as of August 2024), its selectivity for the type II isoform is more than 100 times higher than for type I.

Finasteride at a glance

DHT is the central driver of androgenetic alopecia. Balding scalp carries elevated levels of DHT, and the hormone shortens the growth phase (anagen) of genetically sensitive follicles. With each cycle the hairs grow thinner and shorter, a process called miniaturization. Finasteride targets exactly this root cause.

The dose-finding study by Roberts and colleagues (1999) showed just how strongly finasteride lowers DHT: at 1 mg per day, serum DHT fell by 71.4 percent, and on the scalp itself by 64.1 percent. The dose-response curve flattens out early: even 0.2 mg reached most of the maximum possible reduction, and 5 mg added hardly anything.

That is precisely why 1 mg is the standard dose for hair loss. Finasteride works systemically, meaning throughout the entire body, unlike topical finasteride (more on that below) and unlike minoxidil, which acts purely locally and without touching hormones. To understand how the hair cycle works, with its anagen, catagen, and telogen phases, read our article on the hair cycle.

How well does finasteride work against hair loss?

For most men, finasteride stops or slows hereditary hair loss, and some achieve visible regrowth. The data come from three randomized, placebo-controlled phase III trials in 1,879 men between 18 and 41 years of age (Propecia prescribing information, section 5.1). The most important five-year figures:

• ✓Stabilization: In 90 percent (review photographs) and 93 percent (investigators) of cases, hair loss remained stable over five years.
• ✓Regrowth: An increase in hair growth was seen in 65 percent (hair-count measurement), 48 percent (expert panel), and 77 percent (investigators) of cases.
• ✓Hair counts: +88 hairs after 2 years, still +38 hairs per measurement area after 5 years, compared with -239 hairs on placebo after 5 years.

Kaufman and colleagues (2008) confirmed this independently: over five years, finasteride 1 mg reduced the risk of further visible hair loss versus placebo by 93 percent (95 percent confidence interval 89 to 97, p less than 0.001). Part of the picture is that the placebo group’s numbers dwindled over the years. Even so, the trend in favor of finasteride is clear and has been documented repeatedly.

It is worth being honest about where finasteride works. Its effect is documented above all on the crown and the vertex. For bitemporal recession of the hairline, meaning the classic receding temples, and for end-stage hair loss, the prescribing information explicitly states that no efficacy was demonstrated. Finasteride has no effect on follicles that are already fully lost; it does not make bald zones grow hair again.

That explains why expectations have to match the stage. The Hamilton-Norwood scale helps to gauge the realistic benefit: the earlier the hair loss, the more can be preserved. With extensive baldness, the medication offers little.

Realistic finasteride expectations by Norwood stage

A rough guide, not a prognosis for the individual case. Assessing the stage and choosing a therapy should be left to a doctor.

How fast does finasteride work? The timeline

How fast finasteride works depends on the slow hair cycle: according to the prescribing information, the first signs of stabilization generally appear only after 3 to 6 months of continuous use. Improvements in hair count were greatest after about 2 years and then slowly declined again, but remained clearly better than placebo through year 5.

Individual course. A lack of effect after 12 months should be discussed with your doctor.

A word on user reports and on so-called initial shedding. Unlike with minoxidil, where an initial shedding phase is well documented, the prescribing information does not list initial shedding as a distinct side effect of finasteride. It is described here and there in forums and user reports, but it is not consistently documented and should not be equated with the better-documented minoxidil shedding.

One more thing that shapes experiences with finasteride: those who start late or have a high Norwood stage less often see visible regrowth and more often see preservation. That matches the trial data; it is not a sign of failure but the realistic expectation. Individual reports do not replace medical follow-up.

Taking finasteride correctly: the dosage

The finasteride dose for hair loss is 1 mg per day, with or without food, ideally at the same time of day. Oral bioavailability is around 80 percent and is not affected by food (prescribing information, section 4.2). Important: a higher dose is no more effective according to the prescribing information, because DHT suppression is already near maximal at 1 mg.

The difference between 1 mg and 5 mg is therefore clear: the 5 mg tablet (Proscar, for example) is approved for benign prostate enlargement, not for hair. Quartering it on your own or raising the dose yourself is not a sensible approach. In any case, the effect exists only with continuous use; a one-time course achieves nothing.

The topic of microdosing comes up often, meaning lower doses or taking the drug every other day to reduce side effects. It can be derived in theory from the flat dose-response curve, but there is no controlled study that has compared such a schedule against the daily 1 mg dose on hair-growth endpoints. It remains an off-label, individualized approach that a doctor must supervise, not a standard therapy.

How do I get a finasteride prescription?

You can obtain a finasteride prescription only through a doctor, because the active ingredient is prescription-only (prescribing information, section 11). The first points of contact are your general practitioner, a dermatologist (skin doctor), or a urologist. The doctor makes the diagnosis, counsels you on the benefits and risks, and prescribes finasteride if you are a suitable candidate.

In addition, reputable telemedicine providers offer an online prescription. After a medical questionnaire or a video consultation, a licensed doctor issues the prescription, and the medication comes from a mail-order pharmacy. This route is legal as long as a doctor is genuinely involved and counseling about the risks takes place, including the warnings on mood and suicidal thoughts issued in the 2025 EU-wide safety review.

What does finasteride cost? Original, generics, and insurance

As a generic, finasteride costs roughly 15 to 30 euros per month as of 2026, depending on the provider and pack size; the original product, Propecia, is well above that. Because finasteride for hair loss is not covered by insurance, patients pay this amount themselves.

The active ingredient is identical in the original and the generic. Since the patent expired, there are numerous 1 mg generics that contain the same active ingredient at the same dose and are usually many times cheaper than the original Propecia. Medically, there is no difference in effect between the original and an officially reviewed generic. Price is therefore the main argument for a generic.

Public health insurers generally do not reimburse finasteride for hair loss, not even with a prescription, because it is treated as a so-called lifestyle medication. For the prostate indication (5 mg), the reimbursement situation can look different, but that does not concern the hair-loss treatment.

Topical finasteride: the alternative you apply to the scalp?

Topical finasteride is applied directly to the scalp as a solution or spray and is meant to lower DHT locally, with a lower systemic burden. In parts of Europe it has moved beyond the compounding gray area: with Finjuve (2.275 mg/ml spray, manufacturer Almirall), there is now an approved finished medicinal product, applied once daily with 1 to 4 sprays in men aged 18 to 41.

Alongside this, individual pharmacy compounds are still available, such as a finasteride hair lotion at 0.15 percent, often combined with minoxidil. These have not gone through a licensing study of their own. The rationale for topical finasteride is the smaller drop in blood DHT and therefore potentially fewer systemic side effects. The long-term evidence, however, is thinner than for the oral product.

Does finasteride distort the PSA value?

Yes, finasteride lowers the PSA value, the most important blood marker in prostate cancer screening. The prescribing information states the practical rule verbatim: “A doubling of the PSA value should be considered in men taking Propecia before this test result is assessed.” Anyone taking finasteride must therefore tell every treating doctor about it.

Specifically, mean PSA in the studies of young men fell from 0.7 to 0.5 ng/ml after 12 months. The widespread rule of thumb of a halving comes from studies in older men on the 5 mg dose. It therefore makes sense to have a baseline PSA measured before starting therapy, so that later checks can be interpreted correctly.

A common misunderstanding concerns the prostate cancer risk. The often-cited PCPT study examined 5 mg finasteride in men over 55 for cancer prevention, not the 1 mg hair-loss indication. There, the overall rate of prostate carcinomas fell by 24.1 percent, while the share of higher-grade tumors was slightly increased. Transferring these data to the hair-loss treatment of young men would be misleading. To learn what a sensible blood test for hair loss looks like, read the separate article.

What side effects does finasteride have?

The most common finasteride side effects concern sexual function: reduced libido, erectile and ejaculation problems. According to the prescribing information, sexual side effects occurred in the first year in 3.8 percent of finasteride users versus 2.1 percent on placebo. Over the following four years, the frequency dropped to 0.6 percent. About 1 percent discontinued treatment for this reason in the first year.

• •Sexual side effects are usually reversible and decrease over the course of treatment.
• •Depression is listed as “uncommon,” but in the randomized trials there was no difference from placebo.
• •Lumps, pain, or discharge from the breast should be evaluated by a doctor without delay (rare reports of male breast cancer).

Frequency categories of the prescribing information: uncommon = 1 to 10 per 1,000, “not known” = cannot be estimated from the available data (spontaneous reports). This does not replace medical counseling.

Balance matters here: finasteride is neither harmless nor does it “guarantee impotence.” Most men tolerate it well; a meaningful share of men notice sexual side effects, which usually recede after they stop. Interactions with other medications are minor according to the prescribing information (metabolized via CYP3A4), yet medical counseling before starting remains mandatory.

Post-finasteride syndrome and psychological effects: what is established?

Post-finasteride syndrome (PFS) is the name given to sexual, physical, and psychological complaints that are said to persist after stopping finasteride. Whether finasteride is the cause of these complaints has not been conclusively settled scientifically. The authorities take the reports seriously, but clear proof of causation is still lacking (as of 2026).

The rules have tightened step by step. In 2012 the U.S. authority, the FDA, added notes on sexual dysfunction that can persist after stopping. In 2017 the EMA added a warning on mood changes including depression and, more rarely, suicidal thoughts, and assessed a causal link as “at least a plausible possibility.”

The most recent and most important piece of evidence comes from an EU-wide safety review concluded in 2025 (EMA). It identified 325 relevant cases of suicidal thoughts in the EudraVigilance database. Since then, 1 mg packs include a patient card. At the same time, the committee concluded that the benefit of finasteride continues to outweigh the risks.

Scientifically, PFS is disputed as a distinct clinical entity. A survey of Spanish dermatologists (2025) found that 98.1 percent consider PFS to be more likely psychiatric or caused by a nocebo effect. Other, mechanistically oriented studies, by contrast, report measurable biological differences. Neither “PFS is proven” nor “PFS is pure imagination” holds up scientifically.

Stopping finasteride: what happens then?

If you stop finasteride, DHT rises again and hereditary hair loss continues. According to the prescribing information, the effects reverse within 6 months, and after 9 to 12 months the original, untreated state is reached again. The hair that the therapy had preserved is lost during this period.

This leads to one key consequence for the decision: finasteride is a long-term therapy, not a one-time course. Anyone who wants to keep the result takes it continuously. Stopping should happen in consultation with a doctor, especially when the reason is side effects, so that alternatives can be reviewed together.

Can women take finasteride?

Finasteride is contraindicated for women of childbearing age. Because it inhibits the formation of DHT, taking it during pregnancy can lead to malformations of the external genitalia of male fetuses (teratogenicity). Women who are pregnant or potentially pregnant must not even touch broken or crushed tablets, because of possible absorption through the skin.

There is also one often-overlooked point about finasteride in women: in postmenopausal women with androgenetic alopecia who were treated for 12 months with finasteride 1 mg, the licensing study could not demonstrate any efficacy. A Cochrane review rates the evidence in women overall as insufficient.

In women, diffuse hair loss also frequently has other causes, such as iron deficiency or a thyroid disorder. So before any drug is discussed, the cause needs to be worked up. More on this in the article on hair loss in women, and on hormones in the article on hormones and hair.

Finasteride, minoxidil, or dutasteride?

Finasteride, minoxidil, and dutasteride act at different points: finasteride and dutasteride lower DHT (the cause), while minoxidil locally extends the growth phase without touching hormones. The European S3 guideline on androgenetic alopecia (EDF, Kanti and colleagues 2018) lists topical minoxidil 5 percent and oral finasteride 1 mg as therapies with a high level of evidence.

• •Combination: A meta-analysis of 7 randomized studies (n=396) found the combination of minoxidil and finasteride more effective than either monotherapy.
• •Dutasteride: inhibits both enzyme types and lowers DHT more strongly (about 90 to 93 percent), but in many countries it is only approved for the prostate. Its use for hair loss is off-label.

The comparison is factual, not a treatment recommendation. Which option or combination fits depends on the stage, the age, and individual tolerance, and it belongs in a doctor’s assessment. Another, newer active ingredient is topical clascoterone, which blocks DHT locally at the follicle and is described in the article on clascoterone.

Diffuse or genetic? When finasteride is the wrong approach

Finasteride works exclusively against androgenetic, meaning hereditary, hair loss, recognizable by the pattern of receding temples and a thinning crown or vertex. Diffuse hair loss across the whole head, caused by iron deficiency, a thyroid disorder, or other reasons, does not respond to finasteride. Here the cause needs to be worked up first, and often both forms occur at the same time.

That is why it pays to look at the pattern. Diffuse thinning without a clear pattern points more toward telogen effluvium, for instance from an iron deficiency or a thyroid disorder. A look at the causes of hair loss and the article on androgenetic alopecia helps with sorting this out.

This is exactly where a hair analysis comes in. It clarifies which type is present before any decision about treatment is made. In advanced androgenetic alopecia with follicles already lost, finasteride can stabilize the existing hair but cannot make bald zones grow hair again. For such zones, a hair transplant (FUE extraction plus DHI implantation) is the established, permanent option, because it transplants DHT-resistant hair from the back of the head.

Medication and transplant do not rule each other out. Accompanying drug-based maintenance is common practice, to protect the non-transplanted hair that remains DHT-sensitive, while the transplanted hair stays. Elithair’s free hair analysis is a visual pattern analysis and helps to tell the genetic type from the diffuse type. It does not replace a medical blood test, which you should always have done if a deficiency is suspected.

Conclusion: finasteride at a glance (as of 2026)

Finasteride is the most effective oral standard therapy against hereditary hair loss in men and, in the licensing trials, stabilized around 90 percent of users over five years. It is a long-term therapy, works only on the androgenetic pattern and above all on the crown, and its effect ends when you stop.

At the same time, it carries real side effects, from sexual dysfunction to the warnings on mood and suicidal thoughts confirmed in the 2025 EU-wide safety review. Benefit and risk can only be weighed individually and with a doctor, especially where there are plans to father children, a psychiatric history, or tolerance problems. The first step always remains a clean diagnosis.

Frequently asked questions about finasteride

Scientific sources